Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Haimanti Ray

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Drug Safety|January 17, 2019
Safety and Tolerability of Sonic Hedgehog Pathway Inhibitors in CancerRichard L Carpenter, Haimanti Ray
Biorxiv : the Preprint Server for Biology|August 6, 2025
DNA Circle-sequencing lowers the single molecule sequencing error threshold and identifies ultrasonication as a source of DNA damageStephan Baehr, Jean-Francois Gout, Lauren Reyes, et al.
The FEBS Journal|January 26, 2022
AKT1 mediates multiple phosphorylation events that functionally promote HSF1 activationWen-Cheng Lu, Ramsey Omari, Haimanti Ray, et al.
Biorxiv : the Preprint Server for Biology|June 25, 2024
MYC and HSF1 Cooperate to Drive PLK1 inhibitor Sensitivity in High Grade Serous Ovarian CancerImade Williams, Haddie DeHart, Matthew O'Malley, et al.
Cell Stress & Chaperones|March 27, 2025
Amyloidogenesis promotes HSF1 activity enhancing cell survival during breast cancer metastatic colonizationNatasha Hockaden, Gabi Leriger, John Wang, et al.
Cancer Research|October 27, 2023
HSF1 Inhibits Antitumor Immune Activity in Breast Cancer by Suppressing CCL5 to Block CD8+ T-cell RecruitmentCurteisha Jacobs, Sakhi Shah, Wen-Cheng Lu, et al.
Cancer Research Communications|January 20, 2025
MYC and HSF1 Cooperate to Drive Sensitivity to Polo-like Kinase 1 Inhibitor Volasertib in High-grade Serous Ovarian CancerImade Williams, Matthew O'Malley, Haddie DeHart, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Drug Safety|January 17, 2019
Safety and Tolerability of Sonic Hedgehog Pathway Inhibitors in CancerRichard L Carpenter, Haimanti Ray
Biorxiv : the Preprint Server for Biology|August 6, 2025
DNA Circle-sequencing lowers the single molecule sequencing error threshold and identifies ultrasonication as a source of DNA damageStephan Baehr, Jean-Francois Gout, Lauren Reyes, et al.
The FEBS Journal|January 26, 2022
AKT1 mediates multiple phosphorylation events that functionally promote HSF1 activationWen-Cheng Lu, Ramsey Omari, Haimanti Ray, et al.
Biorxiv : the Preprint Server for Biology|June 25, 2024
MYC and HSF1 Cooperate to Drive PLK1 inhibitor Sensitivity in High Grade Serous Ovarian CancerImade Williams, Haddie DeHart, Matthew O'Malley, et al.
Cell Stress & Chaperones|March 27, 2025
Amyloidogenesis promotes HSF1 activity enhancing cell survival during breast cancer metastatic colonizationNatasha Hockaden, Gabi Leriger, John Wang, et al.
Cancer Research|October 27, 2023
HSF1 Inhibits Antitumor Immune Activity in Breast Cancer by Suppressing CCL5 to Block CD8+ T-cell RecruitmentCurteisha Jacobs, Sakhi Shah, Wen-Cheng Lu, et al.
Cancer Research Communications|January 20, 2025
MYC and HSF1 Cooperate to Drive Sensitivity to Polo-like Kinase 1 Inhibitor Volasertib in High-grade Serous Ovarian CancerImade Williams, Matthew O'Malley, Haddie DeHart, et al.
Pageof 1